Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate

Cancer
Dejka M SteinertJonathan C Trent

Abstract

The natural history of gastrointestinal stromal tumor (GIST) has been revolutionized by imatinib mesylate (imatinib) therapy. Before imatinib, Bcl-2 expression in GIST was associated with a worse prognosis or added no additional prognostic value. To the authors' knowledge, the current study is the first to evaluate Bcl-2 expression in pre-imatinib GIST tissue samples as a prognostic marker of progression-free survival (PFS) time in patients treated with imatinib. The cases of 81 patients with GIST who were evaluated between December 15, 2000 and September 1, 2001 were retrospectively reviewed. Clinicopathologic variables were reviewed. GIST cell morphology and patterns of Bcl-2 expression were described. The methods of Kaplan-Meier and the Cox proportional hazards regression model were used for statistical analysis. Sixty-one (75%) patients had tumors that expressed Bcl-2, and 20 (25%) patients had tumors that were negative for Bcl-2. All epithelioid tumors (n = 12) expressed Bcl-2 and tumors with mixed morphology exhibited Bcl-2 expression in the epithelioid component. A trend toward longer PFS for patients whose tumors expressed Bcl-2 at a greater immunohistochemical intensity was observed (20.6 mos for no Bcl-2 expression; 2...Continue Reading

References

Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·W E CarsonM A Caligiuri
Aug 1, 1995·Journal of Pharmacokinetics and Biopharmaceutics·N G BestD J Spiegelhalter
Oct 13, 1998·Virchows Archiv : an International Journal of Pathology·M MiettinenA J Kovatich
Jan 15, 1999·The American Journal of Surgical Pathology·T S EmoryT J O'Leary
Mar 18, 2000·Cancer Metastasis Reviews·M Bar-Eli
Mar 30, 2001·Applied Immunohistochemistry & Molecular Morphology : AIMM·R E CunninghamT J O'Leary
Aug 9, 2001·International Journal of Surgical Pathology·Angel Panizo-SantosJavier Pardo-Mindán
Jul 3, 2002·Human Pathology·Ronald P DematteoGeorge Demetri
Nov 22, 2002·International Archives of Allergy and Immunology·Mehrdad BaghestanianPeter Valent
Aug 26, 2003·The American Journal of Pathology·Karin HartmannBeate M Henz
Apr 24, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·George Z RassidakisL Jeffrey Medeiros
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina R AntonescuPeter Besmer
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher L CorlessMichael C Heinrich
Jan 19, 2005·The Journal of Investigative Dermatology·Satoko KimuraMasako Mizoguchi
Dec 1, 1995·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·H M AlexanderR Gomulkiewicz

❮ Previous
Next ❯

Citations

Feb 1, 2008·Nature Clinical Practice. Oncology·Stefan SleijferJaap Verweij
May 25, 2006·Current Opinion in Oncology·Jonathan C Trent, Robert S Benjamin
Apr 30, 2011·Chinese Journal of Cancer·Jheri DupartJonathan C Trent
Jan 1, 2010·Journal of Cancer Research and Clinical Oncology·Chun-Meng WangYing-Qiang Shi
Dec 8, 2006·Expert Opinion on Therapeutic Targets·Xiao-kun Zhang
Apr 2, 2009·Expert Opinion on Investigational Drugs·Bengt NilssonHåkan Ahlman
Jan 1, 2014·Pathology·Chris Hemmings, Desmond Yip
Sep 22, 2007·Cytopathology : Official Journal of the British Society for Clinical Cytology·R S MearaD C Chhieng
Feb 22, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Chun GaoAi-Ying Wang
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Narasimhan P AgaramCristina R Antonescu
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John C McAuliffe, Jonathan C Trent
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John C McAuliffeJonathan C Trent
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Salvatore RomeoUNKNOWN European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.